Instem

Instem Debt Growth

Delisted

The Year-over-Year Debt Growth of Instem (INS.L) as of Nov 22, 2026 is -43.99 %. In the previous year, Year-over-Year Debt Growth was -19.66 % — a change of 123.82% (lower).

Debt Growth

-43.99 %

YoY

123.82%

Last updated:

Year-over-Year Debt Growth of Instem is 2022 -43.99 % . Year-over-Year Debt Growth of Instem was 2021 -19.66 % . It decreases by 123.82% lower compared to the previous year.

The Instem Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2015
-79.47 GBP
Jan 1, 2016
-71.79 GBP
Jan 1, 2017
-27.27 GBP
Jan 1, 2018
-37.50 GBP
Jan 1, 2019
5,080.00 GBP
Jan 1, 2020
11.97 GBP
Jan 1, 2021
-19.66 GBP
Jan 1, 2022
-43.99 GBP
The Instem Debt Growth history
YEARDebt GrowthYoY
-43.99 %+123.82%
-19.66 %-264.22%
11.97 %-99.76%
5,080.00 %-13,646.67%
-37.50 %+37.50%
-27.27 %-62.01%
-71.79 %-9.66%
-79.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Instem Stock analysis

What does Instem do? Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Instem stock

Year-over-Year Debt Growth of Instem is -43.99 % in 2022.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Instem since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Instem historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Instem

All Key Metrics — Instem